Compiled by Rupeestop LLP, SEBI RIA INA000022701. NAV as on 18 Aug 2026. Factsheet Jun 2026. About · Disclosures
Bajaj Finserv Healthcare Fund Regular Plan- IDCW Reinvestment
Bajaj Finserv Mutual Fund₹11.776
As on 18 Aug 2026
Vs category
| Period | This fund | Category | Rank |
|---|---|---|---|
| 1 year | +19.86% | — | — |
| 3 year | +10.48% | — | — |
| 5 year | +10.48% | — | — |
All Sectoral Pharma and Healthcare funds · Bajaj Finserv Mutual Fund
Returns
From NAVs through 18 Aug 2026
Calendar years
Rolling 1-year · 8 overlapping windows
Fund facts
Fund details from the Jun 2026 factsheet
Where the money is invested
Split by asset type.
By asset type
What the fund holds
39 holdings · portfolio as on 30 May 2026
- 9.07%Divi's Laboratories LtdHealthcare
- 6.73%Apollo Hospitals Enterprise LtdHealthcare
- 6.54%Sun Pharmaceuticals Industries LtdHealthcare
- 6.51%Piramal Pharma LtdHealthcare
- 6.17%Aurobindo Pharma LtdHealthcare
- 5.26%Torrent Pharmaceuticals LtdHealthcare
- 4.52%Rubicon Research LtdHealthcare
- 4.39%Neuland Laboratories LtdHealthcare
- 4.18%Emcure Pharmaceuticals LtdHealthcare
- 3.68%Max Healthcare Institute Ltd Ordinary SharesHealthcare
Concentration
Risk and quality measures
How steady the returns have been.
Return quality
Risk
Who manages this fund
3 fund managers
- SGSorbh Gupta8.7 years in the industryRuns 14 schemes
- NCNimesh Chandan6.7 years in the industryRuns 26 schemes
- SCSiddharth Chaudhary12.6 years in the industryRuns 26 schemes
Other Sectoral Pharma and Healthcare funds
ICICI Prudential Pharma Healthcare and Diagnostics (p.h.d) Fund Growth-InsuredregularCompare
ICICI Prudential Pharma Healthcare and Diagnostics (p.h.d) Fund IDCW PayoutregularCompare
Bandhan Healthcare FundregularCompare
Bandhan BSE Healthcare Index Fund - Regular Plan - GrowthregularCompare
ICICI Prudential Healthcare ETFregularCompare
Axis Healthcare ETF Regular GrowthregularCompare
Motilal Oswal S&P BSE Healthcare ETFregularCompare
Nippon India Nifty Pharma ETF - Growth PlanregularCompare
SIP illustration
₹5,000/mo × 10 years at this fund's 3Y CAGR. Illustration, not a forecast. SIP calculator
Other versions
- directIDCWBajaj Finserv Healthcare Fund Direct Plan- IDCW PayoutNAV ₹9.956
- regularGrowthBajaj Finserv Healthcare Fund Regular Plan - GrowthNAV ₹9.798
- regularIDCWBajaj Finserv Healthcare Fund Regular Plan- IDCW PayoutNAV ₹9.798
- directGrowthBajaj Finserv Healthcare Fund Direct Plan - GrowthNAV ₹9.956
FAQ
What is Bajaj Finserv Healthcare Fund Regular Plan- IDCW Reinvestment NAV today?
- The latest NAV of Bajaj Finserv Healthcare Fund Regular Plan- IDCW Reinvestment is ₹11.776 as on 18 Aug 2026.
How has Bajaj Finserv Healthcare Fund Regular Plan- IDCW Reinvestment performed vs its category?
- 1-year return +19.86%. Past performance does not guarantee future returns.
What are the returns of Bajaj Finserv Healthcare Fund Regular Plan- IDCW Reinvestment?
- Trailing returns from published NAVs: 1 year +19.86%, 3 year +10.48% a year, 5 year +10.48% a year, since our first NAV +10.48% a year. Past performance does not guarantee future returns.
How would a SIP in Bajaj Finserv Healthcare Fund Regular Plan- IDCW Reinvestment have been illustrated?
- The SIP illustration on this page uses ₹5,000 a month for 10 years at this fund's 3-year annualised return of +10.48%. It is not a forecast.
What is the expense ratio and fund size of Bajaj Finserv Healthcare Fund Regular Plan- IDCW Reinvestment?
- For Bajaj Finserv Healthcare Fund Regular Plan- IDCW Reinvestment, the expense ratio is 2.09% and fund size (AUM) is ₹332.52 Cr.
What is the ISIN of Bajaj Finserv Healthcare Fund Regular Plan- IDCW Reinvestment?
- The ISIN for Bajaj Finserv Healthcare Fund Regular Plan- IDCW Reinvestment is INF0QA701AA1.
Mutual fund investments are subject to market risks. Read all scheme related documents carefully before investing. Past performance does not guarantee future returns and is not an indicator of future results.
Figures on this page come from published NAVs and the scheme's monthly factsheet. They are for information only and are not investment advice or a recommendation to buy or sell any scheme.
